Chronic myeloid leukemia: Standard treatment options

2003

1987, Blood, 69, 1280, 10.1182/blood.V69.5.1280.1280

1995, Lancet, 345, 1392, 10.1016/S0140-6736(95)92596-1

2001, Blood, 98, 3074, 10.1182/blood.V98.10.3074

1994, Blood, 84, 4064, 10.1182/blood.V84.12.4064.bloodjournal84124064

2003, Cancer, 97, 1033, 10.1002/cncr.11223

1988, Leuk Res, 12, 453, 10.1016/0145-2126(88)90110-5

1997, N Engl J Med, 337, 223, 10.1056/NEJM199707243370402

2002, Blood, 99, 1527, 10.1182/blood.V99.5.1527

1998, Blood, 91, 1810

2001, Blood, 98, 2922, 10.1182/blood.V98.10.2922

1988, Science, 242, 933, 10.1126/science.3263702

1996, Cancer Res, 56, 100

2003, N Engl J Med, 348, 994, 10.1056/NEJMoa022457

2002, N Engl J Med, 346, 645, 10.1056/NEJMoa011573

2005, Cancer, 103, 1659, 10.1002/cncr.20922

2005, Leukemia, 19, 507, 10.1038/sj.leu.2403664

2005, Hematology Am Soc Hematol Educ Program, 174

2004, Curr Opin Hematol, 11, 35, 10.1097/00062752-200401000-00006

2001, Science, 293, 876, 10.1126/science.1062538

2005, Curr Opin Hematol, 12, 33, 10.1097/01.moh.0000148551.93303.9e

2003, Semin Hematol, 40, 80, 10.1053/shem.2003.50046

2005, Blood, 105, 2631, 10.1182/blood-2004-06-2480

2004, Blood, 104, 3739, 10.1182/blood-2003-12-4276

2005, Cancer Genet Cytogenet, 157, 104, 10.1016/j.cancergencyto.2004.06.014